CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma.
Malignant mesotheliomas are known to produce hyaluronic acid, in contrast to most pulmonary adenocarcinomas which produce neutral mucin. CD44H is the major cell surface receptor for hyaluronic acid. The aim of this study was to investigate immunohistochemically the expression of this antigen in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma and to assess its diagnostic utility in distinguishing the two tumours. Diffuse and intense membranous CD44H immunoreactivity was seen in 15 of 20 (75%) mesotheliomas and in all 20 biopsies of reactive mesothelium. In contrast, focal (< 10% tumour) expression of CD44H was seen in only three of 20 (15%) pulmonary adenocarcinomas. We advocate the use of CD44H as a positive mesothelial marker for incorporation alongside other established immunohistochemical markers used to distinguish mesothelioma from adenocarcinoma.
Attanoos
R L
RL
Department of Hisopathology, University Hospital of Wales, Cardiff, UK.
Webb
R
R
Gibbs
A R
AR
D000230:Adenocarcinoma / Q000276:immunology*; D014408:Biomarkers, Tumor; D004848:Epithelium / Q000276:immunology / Q000473:pathology; D006801:Humans; D018960:Hyaluronan Receptors / Q000096:biosynthesis*; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000276:immunology*; D008654:Mesothelioma / Q000276:immunology*; D010997:Pleural Neoplasms / Q000276:immunology*
D014408:Biomarkers, Tumor; D018960:Hyaluronan Receptors